medigraphic.com

2014, Number 2

<< Back Next >>

Revista Cubana de Angiología y Cirugía Vascular 2014; 15 (2)

Epidemiology of the cerebrovascular diseases of extracranial origin

Puentes MIC

Language: Spanish
References: 30
Page:
PDF size: 52.78 Kb.


ABSTRACT

Introduction: the cerebrovascular illnesses are a world health problem; they hold the third place among the diseases in Cuba, but the particular place of the carotid artery diseases is still unknown.
Objectives: to update the epidemiologic information on the cerebrovascular diseases, particularly those of extracranial origin.
Methods: the information was collected from the following databases: register of trials of the Cochrane Peripheral Vascular Diseases Group, the Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Library, MEDLINE, PubMed, leading journals with cerebrovascular disease studies, and articles in different web pages published in the last five years. The subject headings were epidemiology, cerebrovascular illness, carotid disease.
Information synthesis: in the western countries, the cerebrovascular diseases are the third cause of mortality after the cardiovascular diseases and neoplasias, accounting for 10% of deaths. They are the first cause of disability in the adult and the second cause of dementia. According to the World Health Organization, 15 million persons suffer ictus every year; 5.5 millions die (10 % of all deaths) and 5 millions show some permanent disability. Although the incidence rate is higher in the elderly, a shift to youngest ages has been observed.
Conclusions: the cerebrovascular disease is a prevailing illness with high morbidity and mortality rates, which demands a lot of care and hospitalization with considerable health and social costs.


REFERENCES

  1. Buergo Zuaznábar MA, Fernández Concepción O. Guías de práctica clínica. Enfermedad cerebrovascular. La Habana: Editorial Ciencias Médicas; 2008 [citado 30 Ene 2014]. Disponible en:http://www.bvs.sld.cu/libros/guia_enf_cerebrovascular/completo.pdf

  2. GJ, Warlow C. Treatment and second prevention of stroke: evidence , costs and effects on individuals and populations. Lancet. 1999;354:1457-63.

  3. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke. 2003;34:2741-8.

  4. PROGRESS Collaborative Group. Randomised trial of a perindopril-based bloodpressure- lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-41.

  5. Feigin VL, Forouzanfar MH, Krishnamurthi RF, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of stroke during 19902010: findings from the Global Burden of Disease Study 2010. The Lancet. 2014 [cited 2013 Mar 3];383(9913):245- 55. Available from: http://www.thelancet.com/journals/lancet/article/PIIS0140 - 6736%2813%2961953-4/fulltext#article_upsell

  6. Sacco RL, asner SE, Broderick JP, Caplan LR, Connors JJ (Buddy), Culebras A, et al. An updated definition of stroke for the 21st Century. A statement for healthcare professionals from the American Heart Association/ American Stroke Association (AHA/ASA) Expert Consensus Document. Stroke. 2013 [cited 2013 Jul 18];44:2064- 89. Available from: http://stroke.ahajournals.org/content/44/7 /2064.abstract.html doi: 10.1161/STR.0b013e318296aeca

  7. Krishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990—2010: findings from the Global Burden of Disease Study 2010.The Lancet Global Health. 2013;1(5):25981.

  8. MINSAP. Anuario estadístico de Cuba del 2009-2012. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2012 [citado 30 Ene 2014]. Disponible en: http://bvscuba.sld.cu/anuario-estadistico-de-cuba/

  9. Organización Mundial de la salud (OMS). Las enfermedades no transmisibles, un problema de salud de primer orden para el siglo XXI. Estadísticas Sanitarias Mundiales 2012. 2012 [citado 30 Ene 2014]. Disponible en:http://www.who.int/healthinfo/ES_WHS2012_Full.pdf

  10. Organización Mundial de la salud (OMS). Estadísticas Sanitarias Mundiales 2012. 2013 [citado 30 Ene 2014]. Disponible en: http://apps.who.int/iris/bitstream/10665/82062/1/WHO_HIS_HSI_13.1_spa.pdf

  11. Rodríguez Lucci F, Pujol Lereis V, Ameriso S, Povedano G, Díaz MF, Hlavnicka A. In-hospital mortality due to stroke. Medicina (B Aires). 2013;73(4):331-4.

  12. Maniecka-Bryla I, Pikala M, Bryla M. Life years lost due to cardiovascular diseases. Kardiol Pol. 2013;71(10):1065-72.

  13. Chen Q, Smith CY, Bailey KR, Wennberg PW, Kullo IJ. Disease location is associated with survival in patients with peripheral arterial disease. J Am Heart Assoc. 2013;2(5):e0003-04.

  14. González González A, Campillo Motilva R, Morbi-mortalidad por enfermedad cerebrovascular de tipo isquémica. Rev Cubana Med Gen Integr. 2007 [citado 2 Feb 2014];23 (4). Disponible en:http://scielo.sld.cu/pdf/mgi/v23n4/mgi03407.pdf

  15. López-Cancio Martínez E. Aterosclerosis intracraneal asintomática: prevalencia, factores clínicos y biomarcadores asociados [tesis]. Barcelona: Universitat Autónoma de Barcelona, Departamento de Medicina; 2012.

  16. Díez-Tejedor E, Álvarez-Sabín J, Muñoz M, Abiusi G, Del Brutto O. Clasificación de las enfermedades cerebrovasculares. Sociedad Iberoamericana de Enfermedades Cerebrovasculares. Rev Neurol. 2001;33(5):455-64.

  17. Taussky P, Hanel RA, Meyer FB. Clinical considerations in the management of asymptomatic carotid artery stenosis. Neurosurgical Focus. 2011 [cited 2013 Nov 13]:1-9. Available from:http://thejns.org/doi/pdf/10.3171/2011.9.FOCUS11222

  18. Liapis CD, Bell PR.F, Mikhailidis D, Sivenius J, Nicolaides A, Fernandes e Fernandes J, et al on behalf of the ESVS Guidelines Collaborators. ESVS Guidelines. Invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg. 2009;37:S1-S19.

  19. Estol CJ. Diagnostico y tratamiento de la enfermedad carotídea sintomática y asintomática. Primer Congreso Virtual Iberoamericano de Neurología. 1998 [citado 30 Nov 2013]. Disponible en: http://svneurologia.org/congreso/vascular-4.html

  20. González Expósito A, Rodríguez Gurry D, Tamayo Montero E. Marcadores de riesgo de estenosis carotídea en pacientes geriátricos. REIQ. 2009 [citado 30 Nov 2013];12(3):107-9. Disponible en: http://www.reiq.es/REIQ12.3.2009

  21. Khoury JC, Kleindorfer D, Alwell K, Moomaw Ch J, Woo D, Adeoye O, et al. Diabetes Mellitus. A risk factor for ischemic stroke in a large biracial population. Stroke. 2013;44:1500-4.

  22. Sirimarco G, Amarenco P, Labreuche PJ, Touboul P-J, Alberts M, Goto S, et al. Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosis. Stroke. 2013 [citado 30 Nov 2013];44:373-9. Disponible en: http://stroke.ahajournals.org/lookup/suppl/ doi: 10.1161/STROKEAHA.112.673129 /-/DC1

  23. Amarenco P, Lavallée PC, Labreuche J, Ducrocq G, Juliard JM, Feldman L, et al. Prevalence of coronary atherosclerosis in patients with cerebral infarction. Stroke. 2011;42:229.

  24. Calvet D, Touzé E, Varenne O, Sablayrolles JL, Weber S, Mas JL. Prevalence of asymptomatic coronary artery disease in ischemic stroke patients: the PRECORIS study. Circulation. 2010;121:16239.

  25. Polak JF, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, D'Agostino RB Sr. Carotid-wall intima-media thickness and cardiovascular events. New Engl J Med. 2011;365:21321.

  26. Nambi V, Chambless L, Folsom AR, He M, Hu Y, Mosley T, et al. Carotid intimamedia thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis risk in communities) study. J Am Coll Cardiol. 2010;55:16007.

  27. Peters SA, den Ruijter HM, Bots ML, Moons KG. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging sub-clinical atherosclerosis: a systematic review. Heart. 2012;98:17784.

  28. Efthymios D. Avgerinos ED, Liapis CD. Role of lipoproteins in carotid arterial disease. Capitulo 4. En: Gabriel E, Atique Gabriel S, editores. Inflammatory Response in Cardiovascular Surgery. London: Springer-Verlag; 2013.

  29. White CJ. Stroke prevention: carotid stenting versus carotid endarterectomy. F1000 Med Rep. 2010;2(24):2-6. doi: 10.3410/M2-24

  30. Nakano M, Stephen J, Kramer MCA, Ladich ER, Kolodgie FD, Virmani R. Insights into the natural history of atherosclerosis progression. In: Taylor AJ, Villines TC, editores. Atherosclerosis: Clinical perspectives through Imaging. London: Springer-Verlag; 2013. p. 3-12. doi 10.1007/978-1-4471-4288_1




2020     |     www.medigraphic.com